about
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomasLoss of PRDM11 promotes MYC-driven lymphomagenesisNordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma.Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another "double hit" lymphoma with very poor outcome?Lipocalin 2 is protective against E. coli pneumonia.WHO-EORTC classification for cutaneous lymphomas.Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma GroupHypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma.SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study.WHO classification 2008 of myeloproliferative neoplasms: a workshop learning effect--the Danish experience.Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma.WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects.TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.Investigation of MGMT and DAPK1 methylation patterns in diffuse large B-cell lymphoma using allelic MSP-pyrosequencing.Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma.TP53 Gene Status Affects Survival in Advanced Mycosis Fungoides.Microarray-based classification of diffuse large B-cell lymphoma.ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma.Global hypomethylation is an independent prognostic factor in diffuse large B cell lymphoma.Lymphoma of the Eyelid - An International Multicenter Retrospective Study.Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway.A novel xenograft model of cutaneous T-cell lymphoma.Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma.Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas.Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network.Conjunctival Lymphoma--An International Multicenter Retrospective Study.FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations.Genetic and epigenetic alterations of the reduced folate carrier in untreated diffuse large B-cell lymphoma.15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau.
P50
Q24629558-8091E7B9-E3D1-43D6-BCE0-5888D8BB4359Q24645617-B95252FA-DF20-45B1-9492-06B56086112AQ28592585-5BD22269-1960-4C7F-A4FB-D111D5FCCB1CQ33585255-739D82A0-B453-4F71-A5C8-74F4EAD0DC94Q33688416-370F5023-1A21-4C77-8610-76339044FC4EQ34028908-3AE750AA-4301-47F9-9226-7966BBA072FBQ34391006-82822370-1CD9-44AE-9E6C-F9F88EDEBD54Q34594224-1BD76C57-607B-4622-B303-56688035124FQ34654655-23CA098C-0D06-4DD7-854D-34ED9B88A4FCQ34803137-5211A165-3151-4B39-A5C8-B0BFC8791568Q35705470-12D63BBA-6617-4620-B0EC-79BA13C4D688Q36020985-D886BD50-18FC-40CA-B954-762DCFF1C3D7Q36315227-3D23EF73-A697-475A-BF05-6FF99AF6917FQ36825602-AD43E985-107A-4BD8-B2F6-A44FFA7B74A7Q37075919-3AA2FB1F-2112-4558-A06D-3EC441F63684Q37201885-F58CF9BD-0FAF-47A6-96D2-57E69D1DCAB9Q37237464-CF2A2D5C-A729-4C0E-A5DE-DCD05AC28A3BQ37377916-57C62F57-CE54-4042-A53E-C67FB601298FQ37407941-D0EA3482-611D-4D36-AE84-0667A22BEEA7Q38326709-2597B16C-A51C-41F3-8D6A-3676FE46D751Q38363906-0631364C-6B15-44A7-914B-069C44B00AA8Q38853677-854C95F9-8F46-4807-AFFB-0EF326228480Q38956559-C009F7DF-7ED6-455E-AFB2-AC5F31B73377Q39349837-68E51CFA-8800-4F66-8BAA-68926E2BD710Q39586865-710D94B5-36D4-43AD-AABF-E4CE5F004D80Q39680398-C659AC76-F500-4ECC-9D35-8A8B080B5007Q39694577-E364980B-3695-47C9-9B43-5994A6230A0DQ39852196-5E803ADE-307F-4B51-9806-80D1563D8732Q39896371-FFDB35A9-8FD0-427E-B8BF-78B0E0E46E91Q39986367-DE1A13D1-FBE9-434C-93AE-B93AF28F20D1Q40003943-3F59C2E2-005A-45F9-A639-F1DBB7CD2C8AQ40047438-0FDE2694-7255-4CEE-B1CF-37C0960EFDA0Q40513690-CC47066A-82A6-4925-B3E7-E708A7E7A989
P50
description
onderzoeker
@nl
name
Elisabeth Ralfkiaer
@ast
Elisabeth Ralfkiaer
@en
Elisabeth Ralfkiaer
@es
Elisabeth Ralfkiaer
@sl
type
label
Elisabeth Ralfkiaer
@ast
Elisabeth Ralfkiaer
@en
Elisabeth Ralfkiaer
@es
Elisabeth Ralfkiaer
@sl
prefLabel
Elisabeth Ralfkiaer
@ast
Elisabeth Ralfkiaer
@en
Elisabeth Ralfkiaer
@es
Elisabeth Ralfkiaer
@sl